Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02765763 · ClinicalTrials.gov registry record · Phase 4
Clinical Evaluation of Day and Night Skin Care Creams Supplemented With MediCell Technology (MCT)'s Composition of Defensins and Supportive Molecules
A Phase 4 study of Skin Aging and Photoaging of Skin, sponsored by Advanced Dermatology.
- Completed
- Registry status
- Phase 4
- Development phase
- 45
- Enrollment target
- 1
- Study location
NCT02765763 is a Phase 4 study of Skin Aging and Photoaging of Skin that has completed, run by Advanced Dermatology. The registered enrollment target is 45 participants, below the 70-participant average among 9 other Skin Aging trials with a reported enrollment target (36% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02765763, a Phase 4 study of Skin Aging and Photoaging of Skin, has completed, sponsored by Advanced Dermatology.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 45 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a placebo-controlled blinded clinical evaluation of day and night skin care creams supplemented by Medicell Technology's composition of defensins and supportive molecules determine the skin hydration and anti-aging properties of the topical test articles after repeated application to the skin of human subjects.
Conditions Studied
Interventions
- DRUG 2-Minute Reveal Masque
- DRUG 24/7 Barrier Repair Cream
- DRUG 8-in-1 BioSerum
- DRUG Null Formula 2-Minute Reveal Masque
- DRUG Null Formula 24/7 Barrier Repair Cream
Study Locations (1)
Illinois
- Advanced Dermatology, LLC - Lincolnshire
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2016-05 |
| Est. Completion | 2017-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02765763
The ClinicalTrials.gov registry entry for NCT02765763 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 70-participant average among 9 other Skin Aging trials with a reported enrollment target (36% lower). The listed sponsor is Advanced Dermatology, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Skin Aging appearing as the primary indexed condition, and to 5 interventions - of which 2-Minute Reveal Masque is the first listed.
NCT02765763 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT02765763 about?
NCT02765763 is a clinical study titled "Clinical Evaluation of Day and Night Skin Care Creams Supplemented With MediCell Technology (MCT)'s Composition of Defensins and Supportive Molecules". This is a placebo-controlled blinded clinical evaluation of day and night skin care creams supplemented by Medicell Technology's composition of defensins and supportive molecules determine the skin hydration and anti-aging properties of the topical test articles after repeated application to the ski...
What is the current status of trial NCT02765763?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 45 participants. The study started on 2016-05. Estimated completion is 2017-06.
What conditions does trial NCT02765763 study?
This clinical trial studies the following conditions: Skin Aging, Photoaging of Skin.
What interventions are being tested in trial NCT02765763?
The interventions under investigation include: 2-Minute Reveal Masque (DRUG), 24/7 Barrier Repair Cream (DRUG), 8-in-1 BioSerum (DRUG), Null Formula 2-Minute Reveal Masque (DRUG), Null Formula 24/7 Barrier Repair Cream (DRUG).
Who is sponsoring clinical trial NCT02765763?
This trial is sponsored by Advanced Dermatology, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02765763 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Skin Aging
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Clinical Study to Evaluate the Efficacy of Activated Silk™ 27P-α in Subjects, Aged 35-65 Years of Age, to Improve the Signs of Aging
ACTIVE NOT RECRUITING · NA
-
A Clinical Study to Evaluate the Efficacy of Activated Silk™ 27P-α in Subjects, Aged 35-65 Years of Age, to Improve the Signs of Aging, by Comparing to a Placebo
ACTIVE NOT RECRUITING · NA
-
Effect of Topical Sulforaphane on Skin Aging and With Ultraviolet and Visible Light Exposure
ACTIVE NOT RECRUITING · Early Phase 1
-
Clinical Trial to Evaluate the Efficacy of Skin Products to Improve Skin Quality and Health
COMPLETED · NA
-
Thermage CPT for Treatment of Facial and Neck Laxity
COMPLETED · NA
-
Relationship of Skin Related SNP to Topical Skin Care Product
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.